| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:06:02 UTC |
|---|
| Update date | 2019-11-26 02:59:42 UTC |
|---|
| Primary ID | FDB003968 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Nicotine |
|---|
| Description | Nicotine, also known as (S)-nicotine or habitrol, belongs to the class of organic compounds known as pyrrolidinylpyridines. Pyrrolidinylpyridines are compounds containing a pyrrolidinylpyridine ring system, which consists of a pyrrolidine ring linked to a pyridine ring. Nicotine is a very strong basic compound (based on its pKa). Nicotine is a bitter tasting compound. Nicotine has been detected, but not quantified in, several different foods, such as common persimmons, fox grapes, citrus, winter squash, and macadamia nuts. This could make nicotine a potential biomarker for the consumption of these foods. |
|---|
| CAS Number | 54-11-5 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| (-)-Nicotine | ChEBI | | (-)-3-(1-Methyl-2-pyrrolidyl)pyridine | ChEBI | | (-)-3-(N-Methylpyrrolidino)pyridine | ChEBI | | (R)-3-(1-Methyl-2-pyrrolidinyl)pyridine | ChEBI | | (S)-(-)-Nicotine | ChEBI | | (S)-3-(1-Methylpyrrolidin-2-yl)pyridine | ChEBI | | (S)-3-(N-Methylpyrrolidin-2-yl)pyridine | ChEBI | | 1-Methyl-2-(3-pyridyl)pyrrolidine | ChEBI | | 3-(1-Methyl-2-pyrollidinyl)pyridine | ChEBI | | 3-(1-Methylpyrrolidin-2-yl)pyridine | ChEBI | | 3-(2-(N-Methylpyrrolidinyl))pyridine | ChEBI | | 3-(N-Methylpyrollidino)pyridine | ChEBI | | L(-)-Nicotine | ChEBI | | L-3-(1-Methyl-2-pyrrolidyl)pyridine | ChEBI | | L-Nicotine | ChEBI | | (S)-Nicotine | Kegg | | Habitrol | Kegg | | (+)-Nicotine | HMDB | | (R,S)-Nicotine | HMDB | | 1-Methyl-2-(3-pyridal)-pyrrolidene | HMDB | | 1-Methyl-2-(3-pyridal)-pyrrolidine | HMDB | | 1-Methyl-2-(3-pyridiyl)pyrrolidine | HMDB | | 2'-beta-H-Nicotine | HMDB | | 3-(1-Methyl-2-pyrrolidinyl)-pyridine | HMDB | | 3-(1-Methyl-2-pyrrolidinyl)pyridine | HMDB | | 3-(N-Methylpyrrolidino)pyridine | HMDB | | 3-N-Methylpyrrolidine | HMDB | | a -N-Methylpyrrolidine | HMDB | | a-N-Methylpyrrolidine | HMDB | | alpha-N-Methylpyrrolidine | HMDB | | beta-Pyridyl-alpha-N-methylpyrrolidine | HMDB | | D-Nicotine | HMDB | | delta-Nicotine | HMDB | | Destruxol | HMDB | | DL-Tetrahydronicotyrine | HMDB | | Fumeto bac | HMDB | | Methyl-2-pyrrolidinyl)pyridine | HMDB | | Nicoderm | HMDB | | Nicotine polacrilex | HMDB | | R)-(+)-Nicotine | HMDB | | Tartrate, nicotine | HMDB | | Nicotine bitartrate | HMDB | | Nicotine tartrate | HMDB | | Bitartrate, nicotine | HMDB | | Nicotine | ChEBI | | (S)-3-(1-Methyl-2-pyrrolidinyl)pyridine | biospider | | L -1-Methyl-2-[3-pyridyl]pyrrolidine | biospider | | L-nicotine | biospider | | Pyridine, 3-((2S)-1-methyl-2-pyrrolidinyl)- | biospider | | Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)- (9CI) | biospider |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C10H14N2 |
|---|
| IUPAC name | 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine |
|---|
| InChI Identifier | InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1 |
|---|
| InChI Key | SNICXCGAKADSCV-JTQLQIEISA-N |
|---|
| Isomeric SMILES | CN1CCC[C@H]1C1=CN=CC=C1 |
|---|
| Average Molecular Weight | 162.2316 |
|---|
| Monoisotopic Molecular Weight | 162.115698458 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as pyrrolidinylpyridines. Pyrrolidinylpyridines are compounds containing a pyrrolidinylpyridine ring system, which consists of a pyrrolidine ring linked to a pyridine ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyridines and derivatives |
|---|
| Sub Class | Pyrrolidinylpyridines |
|---|
| Direct Parent | Pyrrolidinylpyridines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyrrolidinylpyridine
- Alkaloid or derivatives
- Aralkylamine
- N-alkylpyrrolidine
- Heteroaromatic compound
- Pyrrolidine
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Process | Naturally occurring process: |
|---|
| Role | Environmental role: Industrial application: Biological role: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Liquid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 74.04%; H 8.70%; N 17.27% | CCD |
|---|
| Melting Point | -79 oC | |
|---|
| Boiling Point | Bp 730.5 246.1 ° | CCD |
|---|
| Experimental Water Solubility | 1000 mg/mL | SEIDELL,A (1941) |
|---|
| Experimental logP | 1.17 | HANSCH,C ET AL. (1995) |
|---|
| Experimental pKa | 3.1 | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | [a] D -166 | CCD |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-001i-9400000000-47a036aa305825218fa2 | 2014-09-20 | View Spectrum | | GC-MS | Nicotine, non-derivatized, GC-MS Spectrum | splash10-001i-9500000000-f2d4835c504301f9410e | Spectrum | | GC-MS | Nicotine, non-derivatized, GC-MS Spectrum | splash10-01q9-7900000000-1e2c38b5e4e7aae10d37 | Spectrum | | GC-MS | Nicotine, non-derivatized, GC-MS Spectrum | splash10-001i-9800000000-fe889308f7088d47c31d | Spectrum | | GC-MS | Nicotine, non-derivatized, GC-MS Spectrum | splash10-001i-9500000000-f2d4835c504301f9410e | Spectrum | | Predicted GC-MS | Nicotine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-001i-4900000000-6d65165a4417a6129eeb | Spectrum | | Predicted GC-MS | Nicotine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-00di-0900000000-3e7377f36ca2547f4885 | 2012-07-25 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-001i-2900000000-a505fff3a4028a6f0d52 | 2012-07-25 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-00lr-7900000000-b91a12a16d7688e8679d | 2012-07-25 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - EI-B (HITACHI M-80) , Positive | splash10-01q9-7900000000-10d401d7ffa1c2cdbd9f | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-03di-0900000000-440798524836a27b78b4 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive | splash10-01q9-0900000000-926940dd7f4851dbd73b | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive | splash10-00lr-0900000000-6bccc06d40ab273cf972 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive | splash10-0159-2900000000-f7512c405bb662e040a6 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive | splash10-014i-7900000000-f1781566be5aee88f6ef | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive | splash10-001i-0900000000-09e9b29571abf3a52e44 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QFT , positive | splash10-03di-0900000000-16cdb5f23105be4a892b | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QFT , positive | splash10-03di-0900000000-720fe01876c739a30be0 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QFT , positive | splash10-001i-0900000000-85a813588b57acf531fe | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QFT , positive | splash10-001i-0900000000-93a3dae1577f4f2dda53 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QFT , positive | splash10-001i-1900000000-cb6f8cec40dd9ed35d00 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QFT , positive | splash10-00lr-1900000000-1443b1cf22d2de281898 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-03di-0900000000-440798524836a27b78b4 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-01q9-0900000000-926940dd7f4851dbd73b | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-00lr-0900000000-6bccc06d40ab273cf972 | 2017-09-14 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0900000000-bf73c660c9fef052a3e2 | 2017-07-25 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-1900000000-317ad58e8bc4c3092420 | 2017-07-25 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-053u-9400000000-ea4895202e26a55d8a9b | 2017-07-25 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03di-0900000000-ed813017157d07798ea2 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-03di-1900000000-02ba66ba693d048f19ab | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0006-9400000000-442e757e1da476d883af | 2017-07-26 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 15.09 MHz, CDCl3, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 2D NMR | [1H, 1H]-TOCSY. Unexported temporarily by An Chi on Oct 15, 2021 until json or nmrML file is generated. 2D NMR Spectrum (experimental) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 80863 |
|---|
| ChEMBL ID | CHEMBL3 |
|---|
| KEGG Compound ID | C00745 |
|---|
| Pubchem Compound ID | 89594 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 17688 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB00184 |
|---|
| HMDB ID | HMDB01934 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | BCM12-J:BCM12-J |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | NICOTINE |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00002057 |
|---|
| HET ID | NCT |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Nicotine |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Addictive | | A substance causing physical or psychological dependency, often triggering compulsive use despite negative effects. Its biological role involves activating the brain's reward system, releasing feel-good chemicals like dopamine. Therapeutically, understanding addictive substances informs treatment of addiction disorders. Key medical uses include managing pain, although caution is advised due to the risk of dependency. | DUKE | | Analgesic | 35480 | An agent that relieves pain by reducing or blocking pain signals in the brain, commonly used to manage acute or chronic pain, inflammation, and fever, with therapeutic applications in surgery, injury, and disease treatment. | DUKE | | Anorectic | 50780 | An agent that suppresses appetite, reducing food intake. It plays a biological role in regulating hunger and satiety. Therapeutically, anorectics are used to treat obesity and weight-related disorders, aiding in weight loss and management. Key medical uses include short-term treatment of exogenous obesity and managing weight in patients with type 2 diabetes or other weight-related health issues. | DUKE | | Autonomic nervous system paralytic | 52217 | An agent that disrupts autonomic nervous system function, blocking involuntary actions. Therapeutically, it reduces excessive sympathetic activity, commonly used in managing hypertension, cardiac arrhythmias, and perioperative tachycardia and hypertension. | DUKE | | Autonomic nervous system stimulant | 52217 | An agent that enhances the activity of the autonomic nervous system, regulating involuntary functions. Therapeutically, it increases heart rate, blood pressure, and respiration. Key medical uses include treating hypotension, bradycardia, and neurogenic shock, as well as aiding in anesthesia and critical care. | DUKE | | Anti estrogenic | 35222 | An agent that blocks or reduces estrogen's effects, used to treat hormone-sensitive cancers, such as breast cancer, and manage conditions like endometriosis and uterine fibroids, by inhibiting estrogen's biological role in promoting cell growth. | DUKE | | Anti feedant | | A substance that inhibits normal feeding behavior, found in certain plants, deterring insects and animals from consuming them. Its therapeutic applications include pest control, while key medical uses involve managing insect-borne diseases and reducing crop damage. | DUKE | | Anti-fumitory | | An agent that inhibits the activity of fumitory, a plant-based toxin. Therapeutically, it reduces inflammation and oxidative stress, with applications in managing respiratory and gastrointestinal disorders, and potentially treating conditions like asthma and irritable bowel syndrome. | DUKE | | Cardiovascular | 38070 | A system that transports blood, oxygen, and nutrients throughout the body, playing a crucial role in overall health. Therapeutically, cardiovascular agents manage conditions like hypertension, heart failure, and atherosclerosis, with key medical uses including regulating blood pressure, preventing blood clots, and improving cardiac function. | DUKE | | Cholinergic | 38323 | An agent that stimulates the parasympathetic nervous system by mimicking acetylcholine, enhancing muscle contraction, and regulating various bodily functions. Therapeutically, it treats conditions like glaucoma, myasthenia gravis, and Alzheimer's disease, improving muscle tone, cognition, and eye pressure. | DUKE | | Copaminigenic | 48560 | An agent that enhances dopamine production, playing a role in mood regulation and motor control. Therapeutically, it has applications in managing depression, anxiety, and Parkinson's disease, with key medical uses including treating mood disorders and neurodegenerative diseases. | DUKE | | Ectoparasiticide | 38956 | An agent that kills or repels external parasites, reducing infestations. Therapeutically, it's used to treat conditions like scabies, lice, and mite infestations, providing relief from itching and skin irritation. Key medical uses include topical treatments for parasitic skin infections and prevention of parasite-borne diseases. | DUKE | | Epinephrininergic | | An agent that mimics or enhances the effects of epinephrine, a neurotransmitter involved in the body's "fight or flight" response. It plays a biological role in regulating heart rate, blood pressure, and energy metabolism. Therapeutically, epinephrininergic agents are used to treat conditions such as asthma, anaphylaxis, and cardiac arrest, and have key medical uses in emergency medicine and critical care. | DUKE | | Herbicide | 24527 | A chemical agent that kills or inhibits plant growth, used in agriculture to control weeds and pests. It has no direct biological role or therapeutic applications in human medicine, but its development has led to the creation of related compounds with potential medical uses, such as anticancer agents. | DUKE | | Hyperglycemic | 76916 | An agent that increases blood glucose levels, often used to treat hypoglycemia (low blood sugar) and as a diagnostic tool to assess pancreatic function. | DUKE | | Insecticide | 24852 | An agent that kills or repels insects, used to control pests and prevent disease transmission. Therapeutically, insecticides have applications in public health and veterinary medicine, key medical uses include controlling insect-borne diseases such as malaria, typhus, and Lyme disease. | DUKE | | Nematistat | | An agent that disorients, paralyzes, or confuses nematodes, preventing root infestation, with potential therapeutic applications in agriculture and key medical uses in managing parasitic nematode infections. | DUKE | | Neurotoxic | 50910 | A substance that damages or destroys nerve cells, disrupting normal brain function. It has no therapeutic applications, but is used in research to study neurodegenerative diseases. Key medical uses include understanding and developing treatments for conditions like Alzheimer's and Parkinson's diseases, where neurotoxicity plays a role. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Serotoninergic | 48278 | An agent that modulates serotonin activity, regulating mood, appetite, and sleep. It has therapeutic applications in treating depression, anxiety, and mood disorders, with key medical uses including antidepressants, anxiolytics, and anti-migraine medications. | DUKE | | Tranquilizer | | An agent that induces relaxation and reduces anxiety, used therapeutically to manage anxiety disorders, insomnia, and restlessness, promoting calmness and sedation in individuals. | DUKE | | Anxiolytic | 35474 | An agent that reduces anxiety symptoms, commonly used in managing anxiety disorders, such as generalized anxiety disorder and panic disorder, by modulating neurotransmitters like GABA, promoting relaxation and calming effects. | CHEBI |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | | Name | SMPDB Link | KEGG Link |
|---|
| Nicotine Pathway | SMP00431 | Not Available |
|
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| bitter |
- Ayana Wiener, Marina Shudler, Anat Levit, Masha Y. Niv. BitterDB: a database of bitter compounds. Nucleic Acids Res 2012, 40(Database issue):D413-419. DOI:10.1093/nar/gkr755
|
|
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|